Organovo Holdings, Inc. (ONVO)

[RandolRocketman]

Looks like some vertical integration already in place.

Organovo Holdings Subsidiary Samsara Sciences Launches Commercial Operations to Provide Liver Cells for Research
BY Midnight Trader
— 9:48 AM ET 01/13/2016
09:48 AM EST, 01/13/2016 (MT Newswires) -- Organovo Holdings , a three-dimensional biology company, said Wednesday that its wholly-owned subsidiary, Samsara Sciences, has launched commercial operations. Samsara's core mission is the provision of high-quality primary human liver cells for a wide variety of research applications.
Samsara is expected to serve as a key source of primary human liver cells for Organovo's needs in the preclinical safety and therapeutic tissue markets, allowing the company to optimize its supply chain and operating expenses related to cell sourcing and procurement, the company said.
Samsara will offer a comprehensive selection of human hepatic stellate cells -- a key cell type in the liver that plays a major role in the development of prevalent diseases such as fatty liver disease and fibrosis.
"Cell supply and quality are critical to meeting Organovo's ( ONVO ) goal to change the shape of medical research and practice, including our desire to create a bioprinted liver patch for transplant," said Organovo CEO Keith Murphy.